CORM_1170x120_7-7-20

FDA

FDA approves GSK’s Voltaren Arthritis Pain for O-T-C use

FDA approves GSK’s Voltaren Arthritis Pain for O-T-C use

WARREN, N.J. — The Food and Drug Administration has approved Voltaren Arthritis Pain as an over-the-counter remedy for arthritis pain, GlaxoSmithKline said Tuesday.  With the FDA’s approval, Voltaren Arthritis Pain becomes the first and only prescription strength, nonsteroidal anti-inflammatory (NSAID) topical gel for arthritis pain available O-T-C in the United States. Voltaren Gel, which GSK Consumer

Chains pull Zantac from shelves

Chains pull Zantac from shelves

NEW YORK — Pharmacy chains CVS, Walgreens and Rite Aid and other retailers are pulling heartburn medication Zantac and its store-brand versions from their shelves after the Food and Drug Administration (FDA) warned it had detected low levels of a cancer-causing chemical in samples of the drug. The actions follow the FDA’s release of a

AAHP celebrates growth of homeopathy

AAHP celebrates growth of homeopathy

BALTIMORE — The American Association of Homeopathic Pharmacists (AAHP) convened its inaugural industry summit here last month to celebrate recent gains in the marketplace while assessing the challenges suppliers face in engaging with regulators and earning consumers’ trust. “We have a responsibility to produce products of the highest quality so that consumers and families across